Respiratory Adverse Effect

Respiratory adverse effect encompasses pulmonary complications from pharmaceutical use. Chemotherapy-induced pulmonary fibrosis causes progressive dyspnoea. ACE inhibitor-associated cough affects patient adherence. Bronchial hyperresponsiveness increases asthma risk. Respiratory depression from opioids necessitates careful monitoring.

Clinical monitoring detects respiratory changes early. Pulmonary function testing quantitates airflow changes. Imaging surveillance identifies structural changes. Regulatory submissions highlight respiratory risks. Post-approval monitoring identifies respiratory patterns.